Georgia vs Norway: The number of people with susceptibility test result for rifampicin
Georgia
99.79
in 2021
Norway
98.57
in 2021
Georgia rank
33rd
Norway rank
36th
The number of people with susceptibility test result for rifampicin over time
- Georgia
- Norway
How they compare
Georgia currently reports 99.79 against 98.57 in Norway, a difference of 1.22.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Norway ahead.
Georgia ranks 33rd and Norway ranks 36th of 146 countries.
Georgia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Georgia | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.27 | 95.09 | 3.18 | Georgia |
| 2020s | 99.8 | 98.68 | 1.13 | Georgia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Georgia or Norway?
- Georgia, at 99.79 against 98.57 in Norway as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Georgia and Norway?
- 1.22, with Georgia ahead.
- How many years of comparable data are there for Georgia and Norway?
- 5 years are reported by both, from 2017 to 2021.
- How do Georgia and Norway rank globally for the number of people with susceptibility test result for rifampicin?
- Georgia ranks 33rd and Norway ranks 36th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.